Hogan Lovells Publications | A Seat at the Table | 14 November 2019
FSMA update: FDA announces continuation of enforcement discretion for co-manufacturer supplier verification
On 6 November 2019 the U.S. Food and Drug Administration (FDA) announced in a Constituent Update that it will continue to exercise enforcement discretion with respect to certain supply-chain program requirements applicable to contract manufacturers (co-manufacturers).
The agency is taking this action to address situations where brand owners perform certain supply-chain program requirements on behalf of their co-manufacturers.
Back To Listing
Contacts
Senior Counsel
Washington, D.C.
Partner
Washington, D.C.
Partner
Washington, D.C.
Senior Associate
Washington, D.C.
